Dexco PP&E per Employee
The PP&E per Employee of Dexco (DXCO3.SA) as of Oct 22, 2026 is 576,182.67 BRL. In the previous year, PP&E per Employee was 569,695.60 BRL — a change of 1.14% (higher).
Get this data via API
Financial Data API
PP&E per Employee
576,182.67BRL
YoY
1.14%
Last updated:
The Dexco PP&E per Employee history
3 Years
10 Years
25 Years
Max
| YEAR | PP&E per Employee | YoY |
|---|---|---|
| 576,182.67BRL | +1.14% | |
| 569,695.60BRL | +8.08% | |
| 527,095.02BRL | +16.66% | |
| 451,818.39BRL | +22.12% | |
| 369,980.46BRL | +5.41% | |
| 350,996.49BRL | -11.86% | |
| 398,228.84BRL | +17.96% | |
| 337,599.94BRL | -7.43% | |
| 364,703.12BRL | +1.73% | |
| 358,505.20BRL | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Dexco Stock analysis
Frequently Asked Questions about Dexco stock
PP&E per Employee of Dexco is 576,182.67 BRL in 2025.
PP&E per Employee of Dexco changed from 569,695.60 BRL to 576,182.67 BRL, representing a 1.14% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of PP&E per Employee Dexco since 2006 – with annual values, charts, and detailed analysis.
PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.
PP&E per Employee's BRL is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's Dexco historically and in real time.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Workforce — Dexco
All Key Metrics — Dexco
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth